Novartis | Dochód Netto



Net Income Zmiana Data
AbbVie USD 1.29B 1.31B 2025-03
Alcon AG USD 284M 21M 2024-12
Almirall EUR 7.99M 590K 2024-06
Amgen USD 627M 2.2B 2024-12
AstraZeneca USD 2.92B 1.42B 2025-03
Autolus Therapeutics Ltd -27611000 54.48M 2024-12
Bayer EUR -335000000 3.85B 2024-12
Biogen USD 266.7M 121.8M 2024-12
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Fresenius EUR 240M 86M 2024-12
Fresenius Medical Care EUR 66.9M 146.1M 2024-12
Galapagos EUR -153403000 178.71M 2025-03
Genmab DKK 3.84B 2.58B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
GRIFOLS EUR 68.97M 17.28M 2024-12
Hikma Pharmaceutical USD 226M 167M 2024-06
J&J USD 11B 7.57B 2025-03
Lonza CHF 329M 85M 2024-06
Merck EUR 667M 142M 2024-12
Merck USD 5.08B 1.34B 2025-03
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Novo Nordisk 27.3B 7.25B 2024-09
Orion EUR 61.2M 12.2M 2025-03
Pfizer USD 2.97B 2.56B 2025-03
Philips EUR -335000000 516M 2024-12
Recordati EUR 113.03M 11.25M 2024-09
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
UCB EUR 104M 72M 2024-06



Novartis Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.